
Caticap-DT Tablet

Save more with additional offers



Save more with additional offers






General Information







Product introduction
Caticap-DT Tablet should be taken with food within 30 minutes after eating a meal. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include vomiting, weakness, nausea, abdominal pain, and diarrhea. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Uses of Caticap-DT Tablet DT
Benefits of Caticap-DT Tablet DT
Caticap-DT Tablet is used to treat breast cancer, especially when other treatments have not worked. It helps slow the growth of cancer cells, shrink tumors, and may reduce the chance of cancer spreading further.
In colon and rectal cancer, Caticap-DT Tablet is used to control disease progression, shrink tumors, and improve the effectiveness of surgery or radiation. It can also reduce the risk of the cancer coming back after treatment.
Side effects of Caticap-DT Tablet DT
- Dehydration
- Constipation
- Eye irritation
- Nausea
- Anemia (low number of red blood cells)
- Hand-foot syndrome
- Fever
- Pain
- Fatigue
- Vomiting
- Diarrhea
- Paresthesia (tingling or pricking sensation)
- Weight loss
- Stomatitis (Inflammation of the mouth)
- Hair loss
- Breathlessness
- Low blood platelets
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Edema (swelling)
- Increased bilirubin in the blood
- Abdominal pain
How to use Caticap-DT Tablet DT
How Caticap-DT Tablet DT works
Quick tips
- Caticap-DT Tablet is used alone or in combination with other medicines for the treatment of colon, rectum or breast cancers.
- It is oral chemotherapy, hence it is preferred by many patients.
- It should be taken within 30 minutes after eating a meal.
- The dose and the number of treatment cycles needed will depend on the type and stage of cancer that is being treated.
- It may cause dizziness and tiredness. Don't drive or do anything requiring concentration until you know how it affects you.
- Frequency of hair loss is much less compared to other chemotherapy drugs.
- Do not take it if you are pregnant or breastfeeding.
- Your doctor may regularly monitor your blood cells during treatment with this medicine. Inform your doctor immediately if you notice signs of infection such as fever, sore throat, rash or severe diarrhea.
- Inform your doctor immediately if you start to have side effects such as diarrhea, vomiting, nausea, mouth sores, chest pain or loss of appetite.
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney
Use of Caticap-DT Tablet is not recommended in patients with severe kidney disease.

Liver
Use of Caticap-DT Tablet is not recommended in patients with severe kidney disease.
Interaction with drugs
Pegfilgrastim (Injection Route)
Sargramostim (Injection Route)
Lenograstim (Injection Route)
Molgramostim (Injection Route)
Frequently asked questions
Fact Box
Chemical Class
Habit Forming
Therapeutic Class
Action Class
Related lab tests
References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1698.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 947.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 191.
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Capecitabine. [Updated 2018 Dec 3]. [Accessed 18 Feb. 2020] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Fresenius Kabi. Capecitabine [producr Information]. [Accessed 12 Jun, 2023] (online) Available from:




Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Marketer details
Address: Kailash Business Park Vikhroli - 400079 Mumbai, India
Vendor Details
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)















